JPH02100654A - Novel ground krill meat and production thereof - Google Patents
Novel ground krill meat and production thereofInfo
- Publication number
- JPH02100654A JPH02100654A JP63253476A JP25347688A JPH02100654A JP H02100654 A JPH02100654 A JP H02100654A JP 63253476 A JP63253476 A JP 63253476A JP 25347688 A JP25347688 A JP 25347688A JP H02100654 A JPH02100654 A JP H02100654A
- Authority
- JP
- Japan
- Prior art keywords
- surimi
- krill
- transglutaminase
- btgase
- btg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000239366 Euphausiacea Species 0.000 title claims abstract description 38
- 238000004519 manufacturing process Methods 0.000 title claims description 23
- 235000013372 meat Nutrition 0.000 title claims description 15
- 108060008539 Transglutaminase Proteins 0.000 claims abstract description 25
- 102000003601 transglutaminase Human genes 0.000 claims abstract description 25
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 16
- 244000005700 microbiome Species 0.000 claims abstract description 11
- 241000187747 Streptomyces Species 0.000 claims abstract description 6
- 241000894006 Bacteria Species 0.000 claims abstract description 4
- 235000019465 surimi Nutrition 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 210000003205 muscle Anatomy 0.000 claims description 15
- 239000000654 additive Substances 0.000 claims description 11
- 229910019142 PO4 Inorganic materials 0.000 claims description 5
- 239000010452 phosphate Substances 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 4
- 241000251468 Actinopterygii Species 0.000 abstract description 7
- 235000020993 ground meat Nutrition 0.000 abstract 2
- 238000002386 leaching Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 34
- 102000004190 Enzymes Human genes 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 20
- 239000000047 product Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 235000002639 sodium chloride Nutrition 0.000 description 9
- 239000000758 substrate Substances 0.000 description 8
- 101710123874 Protein-glutamine gamma-glutamyltransferase Proteins 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 108010043137 Actomyosin Proteins 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010016807 Fluid retention Diseases 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108060008487 Myosin Proteins 0.000 description 2
- 102000003505 Myosin Human genes 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- -1 etc. Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- JIMLDJNLXLMGLX-JTQLQIEISA-N (2s)-5-amino-5-oxo-2-(phenylmethoxycarbonylamino)pentanoic acid Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 JIMLDJNLXLMGLX-JTQLQIEISA-N 0.000 description 1
- SOUXAAOTONMPRY-NSHDSACASA-N 2-[[(2s)-5-amino-5-oxo-2-(phenylmethoxycarbonylamino)pentanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)OCC1=CC=CC=C1 SOUXAAOTONMPRY-NSHDSACASA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241001313700 Gadus chalcogrammus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- BYYNJRSNDARRBX-YFKPBYRVSA-N Gly-Gln-Gly Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O BYYNJRSNDARRBX-YFKPBYRVSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 101000933607 Homo sapiens Protein BTG3 Proteins 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 description 1
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102100026035 Protein BTG3 Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000785681 Sander vitreus Species 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000520730 Streptomyces cinnamoneus Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000082085 Verticillium <Phyllachorales> Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 125000001942 asparaginyl group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 210000000514 hepatopancreas Anatomy 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000004698 iron complex Chemical class 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- YFZOUMNUDGGHIW-UHFFFAOYSA-M p-chloromercuribenzoic acid Chemical compound OC(=O)C1=CC=C([Hg]Cl)C=C1 YFZOUMNUDGGHIW-UHFFFAOYSA-M 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- 241001446247 uncultured actinomycete Species 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Fish Paste Products (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、オキアミ筋肉に微生物由来のトランスグルタ
ミナーゼを作用させて得られる新規なオキアミすり身と
その製造法に関する。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a novel krill surimi obtained by allowing microorganism-derived transglutaminase to act on krill muscle, and a method for producing the same.
(従来の技術)
オキアミすり身は、通常、以下のようにして製造される
。即ち、原料となる!オキアミから、頭、内臓、殻を除
去し、筋肉部位を集めて水晒しを行ない脱水したのち、
添加物を混合してすり身とする。所望により凍結して冷
凍スリ身とする。(Prior Art) Krill surimi is usually produced as follows. In other words, it becomes a raw material! After removing the head, internal organs, and shell from the krill, collecting the muscle parts and dehydrating them by exposing them to water,
Additives are mixed to make surimi. If desired, it is frozen to make frozen surimi.
1qられた不凍結又は冷凍すり身の品質評価は、通常、
づり身から実際にかまぼこを試作し、そのかまぼこの弾
力、凹みなどの物性を機械により測定し、所9Jにより
色、臭い、味などの官能検査を加えることによって行な
われる。The quality evaluation of 1q unfrozen or frozen surimi is usually
This is done by actually making a prototype of kamaboko from the fish paste, measuring its physical properties such as elasticity and denting using a machine, and adding sensory tests such as color, odor, and taste using Tokoro 9J.
オキアミすり身の製造は、以上のような方法によって行
なわれているが、すけそうだらを原料としたJり身に比
べlその品質は、非常に低いのが現状である。その理由
として、様々な事が考えられるが、オキアミずつ身の主
成分であるアクトミオシン(あるいはミオシン)が、す
けそうだらのそれに比べて数百倍不安定で変性しやすい
ことがあげられる。即ち、これはすり身の製造工程に於
ける1fflli管理が非常に難しいことを意味する。Krill surimi is produced by the method described above, but its quality is currently very low compared to Juri surimi made from walleye pollock. There are many possible reasons for this, but one reason is that actomyosin (or myosin), the main component of krill, is hundreds of times more unstable and easily denatured than that of walleye. That is, this means that it is very difficult to control 1fflli in the surimi manufacturing process.
また、bうひとつの理由としては、オキアミの肝膵臓か
ら筋肉にプロテアーゼが浸出し易く、−度筋肉に浸潤し
たブ1コテアーゼはなかなか除去されない点である。Another reason is that protease easily leaks into the muscle from the hepatopancreas of krill, and proteinase that has infiltrated into the muscle is difficult to remove.
従って、このオキアミの筋肉蛋白質の不安定性やプロテ
アーゼの汚染を考慮したすり身の製造方法が求められる
が、現時点において有効な方法はない。したがって、な
んらかの添加物にってこれらの欠点を補う必要があった
。Therefore, there is a need for a method for producing surimi that takes into consideration the instability of krill muscle proteins and the contamination of proteases, but there is currently no effective method. Therefore, it was necessary to compensate for these drawbacks with some kind of additive.
(発明が解決しようとする問題点)
本発明者は、以上のような軽緯に基づき、第4アミjり
身の品質、とくにかまぼこ形成能を改良しようとする添
加物を種々検討した結果、食品に添加し得るものであり
、かつ製品の色、臭い、味に影響をおよぼすこ′となく
、少量で効果の得られる物は見いだせなかった。(Problems to be Solved by the Invention) Based on the above-mentioned circumstances, the present inventor has investigated various additives to improve the quality of the fourth fish fillet, especially the kamaboko-forming ability. We have not been able to find anything that can be added to foods without affecting the color, odor, or taste of the product, and that can be effective in small amounts.
(問題点を解決するための手段)
先に述べたような状況において、本発明者は、更に鋭意
研究を続行した結果、トランスグルタミナーゼ(以下、
TGaseと略記することがある。)がオキアミすり身
の品質を改善することを見いだした。すなわち、すり身
の製造工程中においてTGascを添加することによっ
て、すり身の品′i!i(主に弾力、保水性、しなやか
さく凹みに関係))が茗しく改善されることを知った。(Means for Solving the Problems) Under the circumstances described above, the present inventor further continued his intensive research and discovered that transglutaminase (hereinafter referred to as
It is sometimes abbreviated as TGase. ) was found to improve the quality of krill surimi. That is, by adding TGasc during the surimi production process, surimi products'i! i (mainly related to elasticity, water retention, suppleness, and dents)) has been found to be significantly improved.
また、通常のすり身には品質改良剤として燐酸塩(主と
して、かまぼこに凹みと弾力を付与する目的を有づる。In addition, ordinary surimi contains phosphate as a quality improver (mainly used to give kamaboko fish cakes dents and elasticity).
)が添加される場合が多いが、燐酸塩を添加せずにその
代替としてTGasef添加した場合でb、通常のすり
身とほぼ同等の品質のリリ身を製造できることを知った
。) is often added, but we have learned that if TGasef is added as a substitute without adding phosphate, b, it is possible to produce lili-mi of almost the same quality as normal surimi.
史には、TGaseによりすり身の凍結変性の防止され
ることも知った。Fumi also learned that TGase prevents freezing denaturation of surimi.
そして、このような知見に基づいて、本発明を完成した
。Based on this knowledge, the present invention was completed.
TGaseの添加は、−船釣なすり身製造工程のうち、
採肉工程から後のどこの工程で加えてもよいが、添加物
混合又は水晒しの際に添加するのが実際的であって、こ
うすることによって簡便な操作で大きな効果を得ること
ができる。The addition of TGase is: - In the boat fishing eggplant production process,
Although it can be added at any step after the meat gathering process, it is practical to add it when mixing additives or bleaching with water, and by doing so, you can obtain great effects with simple operations. .
このようにして得られる魚肉すり身は、通常の魚肉すり
鴎と同様に取り扱うことができ、冷凍保管されて流通に
おかれる。The fish meat paste obtained in this way can be handled in the same way as normal fish meat paste, and is kept frozen and distributed.
本発明の魚肉不凍結又は冷凍リリ身の製造法は、採肉工
程以後の工程においてオキアミ筋肉にトランスグルタミ
ナーぜを作用さける以外は、従来のすり身の!11造法
に準するので、前記工程以外については特に説明を要す
るところはない。The method for producing unfrozen or frozen fish meat of the present invention is similar to that of conventional surimi, except that transglutaminase is not applied to the krill muscle in the steps after the meat collection step. Since this method conforms to the No. 11 manufacturing method, no particular explanation is required except for the steps mentioned above.
トランスグルタミナーゼには、その起源によって種々あ
り、例えばモルモットの肝臓から分離したもの(以下、
MTGaseと略記することがある)を挙げることがで
きる。前者のMTGaseは、例えば、特開昭58−1
49G4号に記載の方法でvA製することができる。後
者のBTGaseは、昭和62年特願ノ第165067
号に係わる新規酵素であって、その酵素特性、l選方等
については別項に記載する。本発明で使用するトランス
グルタミナーゼは、その酵素的な特徴および安価に大量
に入手できることからBTGaseである。There are various types of transglutaminase depending on its origin, for example, transglutaminase isolated from guinea pig liver (hereinafter referred to as
(sometimes abbreviated as MTGase). The former MTGase is, for example, disclosed in Japanese Unexamined Patent Application Publication No. 58-1
vA can be produced by the method described in No. 49G4. The latter BTGase is the patent application No. 165067 of 1988.
The novel enzyme related to this issue is described in a separate section regarding its enzyme properties, selection method, etc. The transglutaminase used in the present invention is BTGase due to its enzymatic characteristics and availability at low cost in large quantities.
オキアミすり身の製造工程中、添加物混合工程でオキア
ミ筋肉にトランスグルタミナーゼを添加するには、何ら
の困難もなく、従来の添加物とともにB T G a
s Cを添加量るとよい。一般に、すり身にはその品質
を維持するために糖類が添加されるが、13TQas(
3の効果は糖類の添加によって低下することはない。ま
た、従来の添加物中、燐酸塩は、所望により、従来通り
使用してもよく、あるいはこれを部分的に又は全面的に
TGaSeぐ代替してもよい。There is no difficulty in adding transglutaminase to krill muscle in the additive mixing process during the production process of krill surimi, and it is possible to add transglutaminase to krill muscle together with conventional additives.
It is preferable to add sC. Generally, sugars are added to surimi to maintain its quality, but 13TQas (
The effect of No. 3 is not reduced by the addition of sugars. Also, among the conventional additives, phosphate may be used as usual, or it may be partially or completely replaced by TGaSe, if desired.
BTGaseの原料オキアミ筋肉への添加量は、0.1
〜70001g蛋白、好ましくは、1〜140u/g蛋
白である。添加量が少ないと、原料オキアミ筋肉に対す
るBTGaseの結合量が少なく効果が小ざい。また、
多過ぎると、BTGaseの効果が極めて早く現われる
ために撹拌、成型などの加工操作が難しくなること、得
られた加工品の品質が低下することを認めた。The amount of BTGase added to the raw material krill muscle is 0.1
~70001 g protein, preferably 1-140 u/g protein. If the amount added is small, the amount of BTGase bound to the raw material krill muscle will be small and the effect will be small. Also,
It has been found that if the amount is too high, the effect of BTGase appears very quickly, making processing operations such as stirring and molding difficult, and the quality of the obtained processed product deteriorates.
このBTGaseの添加v1よ、BTGaseのM素話
性が2u/mlJの場合、原料オキアミ筋肉100重量
部に対して0.oo1〜5千tu部、好ましくは0.0
1〜1重市部に相当するが、酵素の精製度合いおJ、び
活性の強さによって添加、)fiを加減する。In this addition v1 of BTGase, when the M speech property of BTGase is 2u/mlJ, 0.00% per 100 parts by weight of raw material krill muscle. oo1 to 5,000 tu parts, preferably 0.0
It corresponds to 1 to 1 parts of the enzyme, but the addition and ) fi should be adjusted depending on the degree of purification of the enzyme and the strength of the activity.
BTGaseは、MTGaseのようにその活性を発現
するための特定物質依存性がないので、MTGaseよ
り使い易い場合も多々ある。Unlike MTGase, BTGase is not dependent on a specific substance to express its activity, so it is often easier to use than MTGase.
水晒し工程でオキアミ筋肉にトランスグルタミナーゼを
作用させるには、次のようにする。すなわち、オキアミ
筋肉に対し、水を加えた原料肉に対して[3T G a
s eを0.001〜51ffi部、好ましくは00
1・〜11重部を加えて撹拌し、脱水、添加物を混合し
てすり身とする。使用する水の猷警よ特に制限はないが
、原料肉と同量程度から5倍呈程までが望ましい。To make transglutaminase act on krill muscles during the water exposure process, do the following. In other words, [3T G a
0.001 to 51 ffi parts of s e, preferably 0.001 to 51 ffi parts
Add 1 to 11 parts by weight, stir, dehydrate, and mix with additives to make surimi. There are no particular restrictions on the amount of water used, but it is desirable to use the same amount of water as the raw meat to 5 times as much.
因みに、オキアミ筋肉すり身は、そのなかに含まれる蛋
白質のうちその殆んどはアクトミオシンであるが、その
池水溶性蛋白質、基質蛋白質が微Mながら含まれており
、複雑な蛋白質の混合系を成している。従来の知見によ
れば、すり身から作られる練り製品の弾力や保水性は、
アクトミオシンの性質に強く影響を受けることが知られ
ている。Incidentally, most of the proteins contained in krill muscle surimi are actomyosin, but it also contains a small amount of water-soluble protein and matrix protein, forming a complex protein mixture system. are doing. According to conventional knowledge, the elasticity and water retention of paste products made from surimi are
It is known that it is strongly influenced by the properties of actomyosin.
したがって、本発明のすり身の製造法において、BTG
aseは主にアクトミオシンに作用していると考えられ
る。すなわち、遊離のミオシンやアクチンおよびその両
者が結合したアクトミオシンにBTGaSeが作用し、
該蛋白質を架橋高分子化していると推定される。しかし
、アクトミオシン以外の蛋白質についても、BTGas
eが竹田していることは十分に考えられるので、これら
の効果がすべて総合された結果どしてすり身の品質が向
上されるものと推定される。Therefore, in the method for producing surimi of the present invention, BTG
Ase is thought to mainly act on actomyosin. That is, BTGaSe acts on free myosin, actin, and actomyosin bound to both,
It is presumed that the protein is cross-linked and polymerized. However, for proteins other than actomyosin, BTGas
Since it is quite conceivable that e is a Takeda effect, it is presumed that the quality of surimi is improved as a result of all of these effects being integrated.
(新規トランスグルタミナーゼBTGase)(1)ト
ランスグルタミナーぜとその由来トランスグルタミナー
ゼ(’rGase)は、ベブヂド鎖内にあるグルタミン
残りのγ−カルボ1−ジアミド基のアシル転移反応を触
媒づ−る酵素である。このTGaseは、アシル受容体
としてタンパク質中のりジン残基のε−アミノ基が作用
すると、分子内及び分子間にε−(γ−Glu)t−y
s栗橋結合が形成される。また水がアシル受容体として
機能するときは、グルタミン残精が脱アミド化されグル
タミン酸残繕になる反応を進行させる酵素である。(Novel transglutaminase BTGase) (1) Transglutaminase and its origin Transglutaminase ('rGase) is an enzyme that catalyzes the acyl transfer reaction of the remaining γ-carbo-1-diamide group of glutamine in the bebudid chain. be. When the ε-amino group of a lysine residue in a protein acts as an acyl acceptor, TGase generates ε-(γ-Glu)t-y within and between molecules.
s Kurihashi bond is formed. Also, when water functions as an acyl acceptor, it is an enzyme that progresses the reaction in which glutamine residue is deamidated to become glutamic acid residue.
TGaseのこのような性質により、TGasCを用い
てタンパク8右溶液又はスラリーをゲル化さVることが
できる。Due to these properties of TGase, TGasC can be used to gel a protein 8 solution or slurry.
T G a S eは、これまでモルモット旧由来のも
の(MTGase)などの動物由来のものが知られてい
るが、動物由来のものは、安価にまた大量に入手するの
が困がであり、タンパク質をゲル化するときは酵素11
11113および基質濃度を共に高くする必要があり、
またCa2′依存性であるので用途が制限される。TGaSe has been known to be derived from animals such as guinea pig old origin (MTGase), but it is difficult to obtain animal-derived products cheaply and in large quantities. Enzyme 11 when gelling proteins
It is necessary to increase both 11113 and substrate concentration,
Furthermore, since it is Ca2'-dependent, its uses are limited.
本発明で使用する新規トランスグルタミナーゼ(B T
G a s e )は、微生物、例えば、ストレプト
ベルチシリウム属の菌により産生きれるものであるが、
微生物由来のTGaseについての報告は現時点ではな
い。The novel transglutaminase (B T
G a se ) can be produced by microorganisms, such as bacteria of the genus Streptoverticillium, but
There are currently no reports on TGase derived from microorganisms.
本発明で使用する微生物由来のBTGaseは安価に供
給され、かつ精製も容易であるので実用性が大である。The microorganism-derived BTGase used in the present invention is available at low cost and is easily purified, so it is highly practical.
また、BTGaseを用いることにより、カルシウム非
存在下又カルシウム存在下のいずれでも酵素(BTGa
、5c)9度及び基質濃度が非常に低いところで品質の
優れたゲル化物を製造できるという利点がある。In addition, by using BTGase, the enzyme (BTGa
, 5c) It has the advantage that a gelled product of excellent quality can be produced at 9 degrees and at a very low substrate concentration.
■BTGaseの製造
BTGaseを産生ずる微生物は、例えば、ストレプト
ベルチシリウム・グリセオカルネウム(3trepto
verticillium griseocarneu
m) IF012776、ストレプトベルチシリウム・
シナモネウム・サブ・Jスビー・シナ七ネ・クム
(3treptoverticillium cinn
amoncu+++ sub sp 。■Production of BTGase The microorganism that produces BTGase is, for example, Streptoverticillium griseocalneum (3treptocalneum).
verticillium griseocarneu
m) IF012776, Streptoverticillium
3treptoverticillium cinn
amoncu+++ sub sp.
cinnamoneum) I F 012852、ス
トレブトベルチシリウムリモバラエンス(S trep
tovert+c+IliumIIobaraense
) I F 013819等があげられる。cinnamoneum) I F 012852, Strebtoverticillium limobaraens (Strep
tovert+c+IliumIIobaraense
) I F 013819 etc.
これら微生物を培養し、トランスグルタミナーゼを取得
づるための培養法及びM製法等は次の通りである。The culture method and M production method for culturing these microorganisms and obtaining transglutaminase are as follows.
培養形態どしては、液体培養、固体培養いずれも可能で
あるが、工業的には深部通気撹拌培養を行うのが有利で
ある。又、使用する培養源としては、一般に微生物培養
に用いられる炭素源、窒層源、無機塩及びその他の微量
栄養源の他、ストレプトベル升シリウム属に属する微生
物の利用出来る栄養源であれば全て使用出来る。培地の
炭素源としては、ブドウ糖、シ:I&!l、ラスターゲ
ン、グリセリン、デャストリン、澱粉等の他、脂肪酸、
油脂、有様faなどが単独で又は組合せて用いられる。Although both liquid culture and solid culture are possible as the culture form, it is advantageous industrially to perform deep aeration agitation culture. In addition, the culture sources to be used include carbon sources, nitrogen sources, inorganic salts, and other trace nutrient sources that are generally used for microbial culture, as well as any nutrient sources that can be used by microorganisms belonging to the genus Streptobercillium. Can be used. Carbon sources for the medium include glucose, ci:I &! In addition to l, lastagen, glycerin, dastrin, starch, etc., fatty acids,
Fats and oils, various types of fa, etc. can be used alone or in combination.
窒素源としては、無機窒素源、if窒素源のいずれも使
用可能であり、無橢窒¥g源としては硝酸アンモニ・ク
ム、硫酸アンモニウム、尿素、硝酸ソーダ、塩化アンモ
ニウム等が挙げられる。又、有機窒素源としては大豆、
米、トウモロコシ、小麦などの粉、糠、脱脂粕をはじめ
コーンステイープリカー、ペプトン、肉エキス、カゼイ
ン、アミノ酸、酵母エキス等が挙げられる。無機塩及び
微Ffi栄養素としては、リン酸、マグネシウム、カリ
ウム、鉄、カルシウム、亜鉛等の塩類の他ビタミン、非
イオン界面活性剤、消泡剤等の菌の生育やBTGase
の産生を促進するものであれば必要に応じて使用出来る
。As the nitrogen source, either an inorganic nitrogen source or an if nitrogen source can be used, and examples of the inorganic nitrogen source include ammonium cum nitrate, ammonium sulfate, urea, sodium nitrate, and ammonium chloride. In addition, soybeans are organic nitrogen sources,
Examples include flour, bran, and defatted lees of rice, corn, and wheat, as well as cornstarch liquor, peptone, meat extract, casein, amino acids, and yeast extract. Inorganic salts and fine Ffi nutrients include salts such as phosphoric acid, magnesium, potassium, iron, calcium, and zinc, as well as vitamins, nonionic surfactants, antifoaming agents, and other substances that can inhibit bacterial growth and BTGase.
Any substance that promotes the production of can be used as necessary.
培養は好気的条件で、培!温度は菌が発育しBTGas
eが産生するvi囲であれば良く、好ましくは25〜3
5℃である。培養時間は、条件により異なるが、[3T
Gascが最も産生される時間まで培養すれば良く、通
常2〜4日程度である。Cultivation is done under aerobic conditions. Temperature increases bacteria growth and BTGas
It is sufficient if the vi range produced by e is sufficient, preferably 25 to 3
The temperature is 5°C. The culture time varies depending on the conditions, but [3T
It is sufficient to culture until the time when Gasc is produced the most, which is usually about 2 to 4 days.
8 T G a s eは液体培養では培養液中に溶解
されており、培1i終了後培養液より固形分を除いた培
湿ろ液より採取、される。8 T Gas is dissolved in the culture solution in liquid culture, and is collected from the culture filtrate after removing the solid content from the culture solution after the completion of culture 1i.
培養ろ液よりBTGaseを精製するには、通常M f
Ia Vに用いられるあらゆる方法が使用出来る。To purify BTGase from culture filtrate, M f
Any method used for IaV can be used.
例えば、エタノール、アセトン、イソブ0ビルアル」−
ル等の有機溶媒による処理、硫安、食塩等により塩析、
透析、限外ろ適法、イオン交換クロマトグラフィー、吸
着クロマトグラフィ、ゲルろ過、吸着剤、等電点分画等
の方法が使用出来る。又、これらの方法を適当に組合せ
る事によりBTGaseの精製度が上る場合は適宜組合
せて行う事が出来る。これらの方法によって得られる酵
素は、安定化剤として各種の塩類、糖類、蛋白質、脂質
、界面活性剤等を加え或いは加えることなく、限外ろ過
濃縮、逆浸透濃縮、減圧乾燥、凍結乾燥、噴霧乾燥の方
法により液状又は固形のBTGaseを得ることが出来
る。For example, ethanol, acetone, isobutylene-
Salting out with ammonium sulfate, common salt, etc.
Methods such as dialysis, ultrafiltration, ion exchange chromatography, adsorption chromatography, gel filtration, adsorbent, and isoelectric point fractionation can be used. In addition, if the degree of purification of BTGase can be improved by appropriately combining these methods, the methods can be combined as appropriate. Enzymes obtained by these methods can be subjected to ultrafiltration concentration, reverse osmosis concentration, vacuum drying, freeze drying, and spraying, with or without the addition of various salts, sugars, proteins, lipids, surfactants, etc. as stabilizers. Liquid or solid BTGase can be obtained by the drying method.
13TQaseの活性測定はベンジルオキシカルボニル
−し−グルタミニルグリシンとヒドロキシルアミンを基
質としてCa2+非存在下で反応を行い、生成したヒド
ロキサム酸をトリクロ【]酢酸存在下で鉄錯体を形成さ
せ52!+n1llの吸収を測定し、ヒドロ4サム酸の
呈を検量線より求め活性を算出する。The activity of 13TQase was measured by reacting benzyloxycarbonyl-glutaminylglycine with hydroxylamine as a substrate in the absence of Ca2+, and forming an iron complex with the generated hydroxamic acid in the presence of trichloro[]acetic acid52! +n1ll absorption is measured, and the activity of hydrotetrasamic acid is determined from a calibration curve.
BTGase活性は、特に記載しないかぎり以Fに記載
づ−る方法により測定した。BTGase activity was measured by the method described in Section F unless otherwise specified.
〈活性測定法〉
試薬A 0.2Mトリス塩酸緩衝液(Fll−16
,0)0.1Mヒドロキシルアミン
0.01 M還元型グルタチオン
0.03 Mベンジル第1−ジカルボニルL−グルタミ
ニルグリシン
試薬8 3N−塩酸
12%−トリクロロ酢酸
5%FeCj! 6H20(0.IN−11C1
に溶解)
上記溶液の1:1:1の浪合液を試薬Bとする。<Activity measurement method> Reagent A 0.2M Tris-HCl buffer (Fll-16
, 0) 0.1M Hydroxylamine 0.01 M Reduced Glutathione 0.03 M Benzyl 1-dicarbonyl L-Glutaminylglycine Reagent 8 3N-Hydrochloric acid 12%-Trichloroacetic acid 5% FeCj! 6H20 (0.IN-11C1
Reagent B is a 1:1:1 mixture of the above solutions.
酵素液の0.057に試薬A 0.5dを加えて混合し
37℃で10分間反応後、試薬Bを加えて反応停止とF
e錯体の形成を行った後525rvの吸光度を測定す
る。対照としてあらかじめ熱失活させた酵素液を用いて
同様に反応さUたものの吸光度を測定し、酵素液との吸
光度差を求める。別に酵素液のかねりにし一グルタミン
酸γーモノヒドロキサム酸を用いて検量線を作成し、前
記吸光度差より生成されたヒドロキサム酸の石を求め、
1分間に1μモルのヒドロ4サム酸を生成する酵素活性
を1単位とした。Add 0.5d of reagent A to 0.057 of the enzyme solution, mix and react at 37°C for 10 minutes, then add reagent B to stop the reaction and F.
After the e-complex formation, the absorbance at 525rv is measured. As a control, the absorbance of a similarly reacted product is measured using an enzyme solution that has been heat-inactivated in advance, and the difference in absorbance from the enzyme solution is determined. Separately, create a calibration curve using monoglutamic acid γ-monohydroxamic acid as a substitute for the enzyme solution, and determine the hydroxamic acid stones produced from the difference in absorbance.
Enzyme activity that produced 1 μmol of hydrotetasamic acid per minute was defined as 1 unit.
(■BTGaseの酵素特性
上のようにして得られる精製BTGase、即ちストレ
ブトベチシリウム・モバランスIF013819のトラ
ンスグルタミナーゼ(BTG−1と命名)、ストレプト
ベルチシリウム・グリセオ力ルネウムI F Q 12
776のトランスグルタミナーゼ(BTG−2と命名)
、ストレプトベルチシリウム・シナモネウム・サブ・エ
スピー・シナモネウムI F Q 12852のトラン
スグルタミナーゼ(BTG−3と命名)についての酵素
化学的性質は次の通り。(■ Enzyme properties of BTGase Purified BTGase obtained as above, namely transglutaminase of Streptoveticillium mobans IF013819 (named BTG-1), Streptoveticillium griseoluneum IF Q 12
776 transglutaminase (named BTG-2)
The enzymatic chemical properties of the transglutaminase (named BTG-3) of Streptoverticillium cinnamoneum subsp. cinnamoneum IF Q 12852 are as follows.
a)至適吐:
基質としてベンジルオキシカルボニル−ルタミニルグリ
シンとヒト【]、ヤシルアミンを使用した場合、37℃
、10分反応で、BTG−1の至適pHは6〜7にあり
、137G−2の至JpHは6〜7句近にあり、BTG
−3の至適pHは6・〜7付近にある。a) Optimum emesis: 37°C when using benzyloxycarbonyl-lutaminylglycine and human [ ], Yacilamine as substrates.
, in a 10-minute reaction, the optimum pH of BTG-1 is between 6 and 7, and the optimum pH of 137G-2 is near 6 and 7.
The optimum pH of -3 is around 6-7.
b)¥適温度:
1gとしてベンジルオキシカルボニル−ルタミニルグリ
シンとヒドロキシルアミンを使用した場合、pト16、
10分反応で、BTG−1の至適温度は55℃付近であ
り、lうTG−2の至適温度は45℃付近であり、B
T G−3の至適温度は45℃付近にある。b)¥ Suitable temperature: When using benzyloxycarbonyl-lutaminylglycine and hydroxylamine as 1g, p.16,
In a 10-minute reaction, the optimal temperature for BTG-1 was around 55°C, the optimal temperature for TG-2 was around 45°C, and the optimal temperature for BTG-2 was around 45°C.
The optimum temperature for TG-3 is around 45°C.
C) pt−1安定性:
37℃、10分間処理で、BTG−1は11N 5〜9
で安定て゛あり、BTG−、2はpt−1 5〜9で安
定であり、BTG−311 1)H 6−9 1’安定
−C アル。C) pt-1 stability: After treatment at 37°C for 10 minutes, BTG-1 was 11N 5-9
BTG-, 2 is stable in pt-1 5-9, BTG-311 1) H 6-9 1' stable-C Al.
d)温度安定性:
Ill−4 7 テ10分1m ’IIL l’l テ
1.i、B TG−1 ハ40’Ct”は88%活性が
残存し、50℃では74%活性が残存し、BTG−24
10℃rハ86%活性が残存り,、50℃テ4556%
活性が残存し、BTG−34J:40℃テ80%活性が
残存し、50℃では53%活性が残存する。d) Temperature stability: Ill-4 7 te 10 min 1 m 'IIL l'l te 1. i, B TG-1 Ha40'Ct'' has 88% activity remaining, 74% activity remains at 50℃, BTG-24
At 10°C, 86% activity remained; at 50°C, 4556% activity remained.
BTG-34J: 80% activity remains at 40°C, and 53% activity remains at 50°C.
C)基質特異性:
各B T G a s eを用い、各種合成IIとヒド
ロキシルアミンとの反応を調べた。いずれのBTGas
eも合成基質がベンジルオキシカルボニルアスパラギニ
ルグリシン、ベンジルオキシカルボニルグルタミン、グ
リシルグルタミニルグリシンの場合反応しない。しかし
合成りB質がペンジルオキシ力ルポニルグルタミニルグ
リシンの場合の反応性は最も高い。この時の各種合成基
質濃度は5g1Mとした。結果は表−1に示される。C) Substrate specificity: Using each BTGase, the reaction between various synthesis IIs and hydroxylamine was investigated. Which BTGas
e also does not react when the synthetic substrate is benzyloxycarbonyl asparaginylglycine, benzyloxycarbonylglutamine, or glycylglutaminylglycine. However, the reactivity is the highest when the synthetic substance B is penzyloxypolonylglutaminylglycine. The concentration of various synthetic substrates at this time was 5g1M. The results are shown in Table-1.
なお、表−1中のCBZはペンジルオギシ力ルボニル基
の略であり、Glnはグルタミル基の略であり、Gly
はグリシル基の略であり、△spはアスパラギニル基の
略である。In addition, CBZ in Table 1 is an abbreviation for penzyloxycarbonyl group, Gln is an abbreviation for glutamyl group, and Gly
is an abbreviation for glycyl group, and Δsp is an abbreviation for asparaginyl group.
表−1
表−2
f)金属イオンの影響:
活性測定系に1 111M濃度になるように各種金属イ
オンを加えて影響を調べた(結束は表−2に示される)
。いずれのBTGasebCu2”zn”cより活性が
用害される。Table-1 Table-2 f) Effect of metal ions: The effects were investigated by adding various metal ions to the activity measurement system at a concentration of 111M (the binding is shown in Table-2).
. The activity is affected by both BTGasebCu2"zn"c.
g)阻害剤の影響:
各阻害剤を1 mMになるように加え、25℃、30分
放置後、活性を測定したく結果は艮−3に示される)。g) Influence of inhibitors: Each inhibitor was added to a concentration of 1 mM, and after standing at 25°C for 30 minutes, the activity was measured (results are shown in Figure 3).
いずれのBTGaseもパラクロロマーキュリ−安息香
酸(PCMBど略する)、N−エチルマレイミド(NE
Mと略する)、七ノヨード酢酸により活性が阻害される
。Both BTGases include parachloromercury-benzoic acid (abbreviated as PCMB), N-ethylmaleimide (NE
(abbreviated as M), the activity of which is inhibited by heptanoiodoacetic acid.
表−3
表−3中PMSFは゛ノエニルメチルスルボニルフルオ
ライドの略である。Table 3 In Table 3, PMSF is an abbreviation for noenylmethylsulfonyl fluoride.
h)等電点:
アンホライン等電点電気泳動により求めたところ、BT
C,−1の等電点f)Iは9付近であり、BTG−2の
等電点piは9,7付近であり、BTG3の等電点1)
[は98付近である。h) Isoelectric point: As determined by ampholine isoelectric focusing, BT
The isoelectric point f) of C,-1 is around 9, the isoelectric point pi of BTG-2 is around 9,7, and the isoelectric point 1) of BTG3 is
[ is around 98.
)分子量:
SDSディスク電気泳動法より求めたところ、BTG−
1の分子量は約38.000であり、BTG20分子船
は約41,000であり、BTG−3の分子量は約41
,000である。) Molecular weight: As determined by SDS disk electrophoresis, BTG-
The molecular weight of BTG-1 is approximately 38,000, the molecular weight of BTG20 is approximately 41,000, and the molecular weight of BTG-3 is approximately 41,000.
,000.
j)MTGaseとの比較:
次にBTGaSeとモルモット肝由来のトランスグルタ
ミナーゼ(MTGasc)との性質を比較する。尚、M
TGaseは、特開昭58−149645号に記載され
た方法で調製した。j) Comparison with MTGase: Next, the properties of BTGaSe and guinea pig liver-derived transglutaminase (MTGasc) will be compared. Furthermore, M
TGase was prepared by the method described in JP-A-58-149645.
表−4には各酵素化学的性質の比較を、表−5にはCa
2+の活性に及ぼす影響を示す。表−4および表−5よ
り明らかのように従来主として研究されているMTGa
seと放線菌由来のBTGaSeとには酵素化学的性質
において種々の差が見られ、特に温度安定性、分子fJ
、rj電点、基質特異性に差が見られる。また、Ca2
4の存在下及び非存在下においてもBTGaseは作用
する点等でもMTGaseとは明らかな差がみられる。Table 4 shows a comparison of the chemical properties of each enzyme, and Table 5 shows Ca
The effect on 2+ activity is shown. As is clear from Tables 4 and 5, MTGa, which has been mainly studied in the past,
There are various differences in enzymatic chemical properties between se and actinomycete-derived BTGaSe, especially in temperature stability and molecular fJ.
, rj electric point, and substrate specificity. Also, Ca2
BTGase is clearly different from MTGase in that it acts both in the presence and absence of 4.
従って、BTGaseの各酵素はMTGaseとはその
性質を異にするものと考えられる。Therefore, each enzyme of BTGase is considered to have different properties from MTGase.
表−4
表−5
(4)BTGase(7)Iffi例
a)B−rG−1の製造
ストレプトベルチシリウム・モバラエンスIF0138
19を培地組成ポリペプトン0.2%、グリコース゛0
.5%、リン酸二カリウム0.2%、硫酸マグネシウム
0.1%からなる培地(吋(7)200ai!に接種し
、30℃、48時聞培養し、得られた種培遷液をポリペ
プトン20%、ラスターゲン2.0%、リン酸二カリウ
ム0.2%、gl酸マグネシウム0.1%、酵母エキス
0.2%、消泡剤としてアデカノール(商品名、旭電化
社製品) 0.05%からなる培地2ON (DH7)
に加え30℃で3日間培養少ろ過し、培養液18.F+
e得た。このものの活性は、0.35u/jIi!rあ
る。Table-4 Table-5 (4) BTGase (7) Iffi Example a) Production of B-rG-1 Streptoverticillium mobaraens IF0138
19, medium composition: polypeptone 0.2%, glycose 0
.. 5% dipotassium phosphate, 0.2% magnesium sulfate, and 0.1% magnesium sulfate. 20%, Lastagen 2.0%, Dipotassium phosphate 0.2%, Magnesium glaate 0.1%, Yeast extract 0.2%, Adekanol (trade name, Asahi Denka product) as an antifoaming agent 0. Medium 2ON (DH7) consisting of 0.05%
In addition, culture at 30°C for 3 days, slightly filtered, and culture solution 18. F+
I got it. The activity of this thing is 0.35u/jIi! There is r.
培養液を塩酸でI)H6,5に調整し、予め0.05M
リン酸緩衝液(pH6,5)で平衡化しておいたCG5
0(商品名、オルガノ社製品)のカラムに通した。The culture solution was adjusted to I) H6,5 with hydrochloric acid, and 0.05M
CG5 equilibrated with phosphate buffer (pH 6,5)
0 (trade name, Organo Co., Ltd. product) column.
この操作でトランスグルタミナーゼは吸着された。Transglutaminase was adsorbed by this operation.
さらに同緩衝液で不純蛋白質を洗い流し1=後、さらに
0.05〜0.5Mの同緩衝液の温度匂配をつくり、通
液して溶出液を分画回収し、比活性の高い分画を集めた
。電導度を10m5以下になるように希釈復ブルーセフ
ァ0−スのカラムに通した。この操作でトランスグルタ
ミナーゼは吸着され!ζ0更に0、05Mリン酸!!衝
液(1)H7)で不純蛋白質を洗い流した復、0〜1M
の食塩濃度匂配をつくり通液して溶出液を回収し比活性
の高い自分を集めた。UF 6000膜を使い濃縮し、
0.5Mの食塩を含む0.05Mリン酸緩衝液(pH7
)で緩衝液を用いて平衡化させた。Furthermore, after washing away impure proteins with the same buffer solution, a temperature gradient of 0.05 to 0.5M of the same buffer solution was created, and the eluate was fractionated and collected by passing through the solution, and fractions with high specific activity were collected. Collected. It was passed through a column of diluted blue Sephas so that the conductivity was less than 10 m5. With this operation, transglutaminase is adsorbed! ζ0 more 0.05M phosphoric acid! ! After washing away impure proteins with buffer solution (1) H7), 0-1M
We created a salt concentration scent of 100%, passed the solution through it, collected the eluate, and collected those with high specific activity. Concentrate using UF 6000 membrane,
0.05M phosphate buffer (pH 7) containing 0.5M sodium chloride
) and equilibrated with buffer.
得られた濃縮液を同緩衝液で予め平衡化しておいたセフ
ァデックスG−75<ファルマシアファインケミカル社
製)を含むカラムに通し、同緩衝液を流して溶出液を分
画した。この結果活性画分は甲−のビークとして溶出さ
れた。このものの比活性【よ、項五る液に対し625倍
であり、回収率は47%であった。The obtained concentrate was passed through a column containing Sephadex G-75 <Pharmacia Fine Chemicals Co., Ltd., which had been equilibrated with the same buffer solution in advance, and the eluate was fractionated by flowing the same buffer solution. As a result, the active fraction was eluted as a peak. The specific activity of this product was 625 times that of the liquid, and the recovery rate was 47%.
b) BTG−2の製造
BTG−1の場合と同様にして、ストレプトベルブシリ
ウム・グリセオカルネウムI F O1277f3を3
0℃で3日間培養後ろ過し、培養液191を(qた。b) Production of BTG-2 In the same manner as in the case of BTG-1, Streptoverbucilium griseocalneum I F O1277f3 was added to 3
After culturing at 0°C for 3 days, the culture solution was filtered.
このものの活性は0.28LJ/dであった。The activity of this product was 0.28 LJ/d.
BTG−1の場合と同様な方法で′M素を精製して、S
D S フイスク電気泳動−C単一の酵素をえた。'M element was purified in the same manner as in the case of BTG-1, and S
D S Fisk electrophoresis-C single enzyme was obtained.
c) B T G −3の製造
BTG−1の場合と同様にして、スト[lブトベルヂシ
リウム・シナモネウム・サブ・エスピー・シナモネウム
I F 012852を30℃で3日培V&後ろ過し、
培養液18.51を得た。このものの酵素活性は0.5
u/dであった。c) Production of BTG-3 In the same manner as in the case of BTG-1, St. Butoverdicillium cinnamoneum subsp.
18.51 of a culture solution was obtained. The enzyme activity of this thing is 0.5
It was u/d.
RTG−1の場合と同様な方法で酵素を精製して、SD
Sディスク電気泳動で単一のwI累を得た。The enzyme was purified in the same manner as for RTG-1, and the SD
A single wI accumulation was obtained by S-disk electrophoresis.
以下、実施例を揚げて本発明を史に説明する。Hereinafter, the present invention will be explained in detail with reference to Examples.
なお、本実滴例においては、BTG−1を主に用いたが
、BTG−2およびB T G−3についても、BTG
−1とほぼ同様な結果が19られた。In this actual droplet example, BTG-1 was mainly used, but BTG-2 and BTG-3 were also used.
19 results were obtained that were almost the same as -1.
(実施例)
実施例に於いて、かまぼこ形成能はレオメータ−で次の
ように測定し、また、部は重社部である。(Example) In the Examples, the kamaboko-forming ability was measured using a rheometer as follows, and the section is Jyushabu.
弾 カニ弾力及び凹みの測定は、レオメータ−及び凹み
(フドーII社製)で、5φブランジ17−を用いて
測定した。リンプルの形状は、直径23mm、高さ30
1III110プランジV−をかまぼこに押し込んだと
きに、
かまぼこが破新するのに要する力を弾
力(y)破斯するまでに移動したプラ
ンジンヤーの距離を凹(+11m)として表わした。The elasticity and dent were measured using a rheometer and dent (manufactured by Fudo II Co., Ltd.) using a 5φ flange 17. The shape of the rimpu is 23mm in diameter and 30mm in height.
When the 1III110 Plunge V- is pushed into the kamaboko, the force required for the kamaboko to rupture is expressed as the elasticity (y), and the distance the plunger moves until the kamaboko breaks is expressed as the concavity (+11 m).
保水性ニー・殻内に、すり食に水を加えると、かまぼこ
の弾力と凹みは低下する。1つ
身に水を加え、弾力が約800gになるように調整する
。このとき加えた水の
Wが多いほどそのすり身の保水性は高
いとする。When water is added to the water-retaining shell, the elasticity and dents of the kamaboko decrease. Add water to each piece and adjust the elasticity to about 800g. It is assumed that the more water W added at this time, the higher the water retention capacity of the surimi.
実施例1
水揚げ直後のオキアミの100部から頭、内蔵、殻を除
去し、残った筋肉(オキアミの尾肉に相当し、むき身と
呼ぶ)を集めて、むき身の3倍量の清水を加え、3分間
撹拌した後脱水した。この脱水肉に添加物として砂糖4
部、ソルビトール4部、燐酸塩0.2部(トリポリ燐酸
塩およびピロ燐酸塩を1対1で混合したちの) 、t3
TG−iを0.02部くわえて混合、凍結して冷凍すり
身とした。対照は、BTG−1を含まないものとした。Example 1 Remove the head, internal organs, and shell from 100 parts of krill immediately after landing, collect the remaining muscle (corresponding to the tail meat of krill, and call it shucked meat), add three times the amount of clean water as the shucked meat, and After stirring for 3 minutes, the mixture was dehydrated. Sugar 4 as an additive to this dehydrated meat
parts, 4 parts of sorbitol, 0.2 parts of phosphate (from a 1:1 mixture of tripolyphosphate and pyrophosphate), t3
0.02 part of TG-i was added, mixed, and frozen to obtain frozen surimi. The control did not contain BTG-1.
(イ)両試作すり身のそれぞれ100部に対して食後、
90℃の湯浴中で20分間加熱し、水冷した。このよう
にして得られたものは一種のかまぼこであって、このも
のについて物性全測定した。(b) After meals for 100 parts of both prototype surimi,
It was heated in a 90°C water bath for 20 minutes and cooled with water. The product thus obtained was a type of kamaboko, and all physical properties of this product were measured.
(ロ)一方、前記両試作すり身をそれぞれ一30℃にて
凍結して冷凍すり身とし、−20℃で1か月間貯蔵した
のち解凍して、(イ)と同様にしてかまぼこを調製し、
このものについて物性を測定した。(b) On the other hand, both of the trial surimi were frozen at -30°C to obtain frozen surimi, stored at -20°C for one month, thawed, and prepared kamaboko in the same manner as in (a);
The physical properties of this product were measured.
表−1
表−2
表1の結果よりB’rG−1を添加したものは、河しく
弾ツノと凹みが政所され、好ましい品質のすり身であっ
た。Table 1 Table 2 From the results in Table 1, the surimi to which B'rG-1 was added had smooth edges and dents, and was of desirable quality.
実施例2
水揚げ直後の第1アミがら実施例1の方法で得たむき身
を2〜30℃の温度で4時間保管し、実施例1に従って
、BTG−1を添加した寸り身を6検体111だ。Example 2 The shelled meat was obtained by the method of Example 1 immediately after landing and stored at a temperature of 2 to 30°C for 4 hours, and 6 specimens of minced meat were added with BTG-1 according to Example 1. is.
各づり身の品質を表−2に示した。The quality of each surimi is shown in Table 2.
この結果より、オニ1アミの保管温度は低い方が望まし
く、好ましくは10℃以下であることが分かる。From this result, it can be seen that it is desirable that the storage temperature of Oni 1 Ami is lower, preferably 10° C. or lower.
実施例3
実施例1で得たオキアミ脱水肉に以下のような添加物を
加えてよく混合したすり身を製造し、20℃で1か月間
貯蔵したのち、解凍してその品質を測定した。Example 3 The following additives were added to the dehydrated krill meat obtained in Example 1 to produce a well-mixed surimi, which was stored at 20° C. for one month, then thawed and its quality was measured.
リンプル番号
添
ソルビトール
ツルごトール
ソルビトール
表−3
物
加
8部
8部、燐M塩 0.2部
8部、BTGo、02部
えて同様にかまぼこを31’!!L、、その品質を比較
した。結果を表4に示した。Sorbitol with Rinple Number Sorbitol Table - 3 Addition 8 parts 8 parts, Phosphorus M salt 0.2 parts 8 parts, BTGo, 02 parts Add kamaboko 31' in the same way! ! L., compared their quality. The results are shown in Table 4.
表−4
実施例4
実施例1の方法で製造した本発明の冷凍すり身を同じ<
−20℃で1か月間貯蔵した後回答し、すり身100部
に対して水40部を加え、その全体重に対し、3部の食
塩を加え、冊潰Iでよく撹ff L、実流例1(イ)に
従ってかまぼこを調製し、品質を評価した。Table 4 Example 4 Frozen surimi of the present invention produced by the method of Example 1 Same <
After storing for one month at -20℃, add 40 parts of water to 100 parts of surimi, add 3 parts of salt to the total weight, and stir well with a shukumasu Iff L, actual flow example. Kamaboko was prepared according to 1 (a) and the quality was evaluated.
また、対照の冷凍すり身には解凍復水を5品揃以上の結
果から、本発明のサリ身は対照にくらべ、より多くの水
を保つことが明らかとなった。Furthermore, from the results of 5 or more items of thawed condensed water in the frozen surimi of the control, it became clear that the surimi of the present invention retained more water than the control.
(発明の効果)
本発明により従来のオキアミすり身に比較し、全く新し
いすり身の製造が可能となった。即ち水沫によって、オ
キアミすり身の著しい品質向上が認められ、今後は、オ
キアミ資源の有効な部用法の1つを提供するものとなる
。(Effects of the Invention) The present invention has made it possible to produce completely new krill surimi compared to conventional krill surimi. In other words, water droplets have been found to significantly improve the quality of krill surimi, and will provide one of the effective ways to use krill resources in the future.
手続補正内Within procedural amendments
Claims (7)
ナーゼを0.1〜700u/g蛋白添加することを特徴
とするオキアミすり身の製造法。(1) A method for producing krill surimi, which comprises adding microorganism-derived transglutaminase at 0.1 to 700 u/g protein to krill muscle.
来のトランスグルタミナーゼを添加することを特徴とす
る請求項1のオキアミすり身の製造法。(2) The method for producing krill surimi according to claim 1, characterized in that microorganism-derived transglutaminase is added to the krill muscle in a step after the water exposure step.
下に保つことを特徴とする請求項1または2記載のオキ
アミすり身の製造法。(3) The method for producing krill surimi according to claim 1 or 2, wherein the temperature of the meat is maintained at 10° C. or lower in the surimi production process.
特徴とする請求項1または2記載のオキアミすり身の製
造法(4) The method for producing krill surimi according to claim 1 or 2, characterized in that the raw material is krill that has been caught within 8 hours.
る請求項1または2記載のオキアミすり身の製造法(5) The method for producing krill surimi according to claim 1 or 2, characterized in that no phosphate is used as an additive.
ム属の菌によつて産生されたものであることを特徴とす
る請求項1記載のオキアミすり身の製造法。(6) The method for producing krill surimi according to claim 1, wherein the transglutaminase is produced by a bacterium of the genus Streptoverticillium.
造された新規なオキアミすり身。(7) A novel krill surimi produced by the method according to any one of claims 1 to 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63253476A JPH02100654A (en) | 1988-10-07 | 1988-10-07 | Novel ground krill meat and production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63253476A JPH02100654A (en) | 1988-10-07 | 1988-10-07 | Novel ground krill meat and production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02100654A true JPH02100654A (en) | 1990-04-12 |
Family
ID=17251915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63253476A Pending JPH02100654A (en) | 1988-10-07 | 1988-10-07 | Novel ground krill meat and production thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02100654A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7108876B2 (en) | 2001-01-25 | 2006-09-19 | Nutricepts, Inc. | Shaped cheese reconstruction with transglutaminase |
WO2016161575A1 (en) * | 2015-04-08 | 2016-10-13 | 江南大学 | Method for dehydrating antarctic krill and extracting shrimp oil |
-
1988
- 1988-10-07 JP JP63253476A patent/JPH02100654A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7108876B2 (en) | 2001-01-25 | 2006-09-19 | Nutricepts, Inc. | Shaped cheese reconstruction with transglutaminase |
WO2016161575A1 (en) * | 2015-04-08 | 2016-10-13 | 江南大学 | Method for dehydrating antarctic krill and extracting shrimp oil |
US10492508B2 (en) * | 2015-04-08 | 2019-12-03 | Jiangnan University | Method for extracting oil from dehydrated Euphausia superba |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5156956A (en) | Transgultaminase | |
El-Sayed | Purification and characterization of a new L-methioninase from solid cultures of Aspergillus flavipes | |
JP2536086B2 (en) | Manufacturing method of tofu that can be stored at room temperature for a long time | |
Kaminogawa et al. | Isolation and characterization of a prolidase from Streptococcus cremoris H61 | |
Khalid et al. | Partial purification and characterization of an aminopeptidase from Lactobacillus helveticus CNRZ 32 | |
JP2572716B2 (en) | Novel transglutaminase | |
JP2594340B2 (en) | How to make cheese food | |
JPH02100654A (en) | Novel ground krill meat and production thereof | |
JP2556109B2 (en) | Material for meat grain | |
JP2590373B2 (en) | New surimi and its manufacturing method | |
JP2540919B2 (en) | Fried fried manufacturing method | |
CA1201325A (en) | Microbial rennet having increased milk coagulating activity and method for production thereof | |
JP2650366B2 (en) | Solid fat and its production method | |
JP2533365B2 (en) | Method of manufacturing fish surimi | |
JP2611408B2 (en) | General-purpose material for paste-like food and method for producing paste-like food | |
JP2782849B2 (en) | Vegetable protein powder and method for producing tofu using the same | |
JPH08224063A (en) | Gelatinized composition of protein | |
JPH0343080A (en) | Production of novel transglutaminase derived from streptoverticillium | |
JP3592811B2 (en) | Low-temperature active alkaline protease, microorganism producing the same, and method for producing the alkaline protease | |
JP2611368B2 (en) | Method for producing protein assembly | |
JP3122993B2 (en) | A novel transglutaminase-containing composition derived from fish liver and a method for producing a protein gel using the same | |
FR2509139A1 (en) | MICROBIAL PROTEIN ISOLATION WITH REDUCED NUCLEIC ACID CONTENT | |
JP3592795B2 (en) | Low-temperature optimal alkaline protease, microorganism producing the same, and method for producing the alkaline protease | |
JPH0799942A (en) | Preparation of 'karashi-mentaiko' | |
JPH02186961A (en) | Fish meat kneaded product and production thereof |